Article info
PDFLetter
Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use
- Correspondence to Nadir Yalçın, Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey; nadir.yalcin{at}hotmail.com
Citation
Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use
Publication history
- First published April 27, 2023.
Article Versions
- Previous version (27 April 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.